Clinical Trials Browser

Phase 2 × Carcinoma, Intraductal, Noninfiltrating × Zoledronic Acid × Clear all

NCT01194440 2018-09-12

Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms

Phase 2 Completed

63 enrolled 7 charts

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating